Talking to the synapse: How antidepressants can target glial cells to reshape brain circuits

Current Drug Targets

Volumn 14, Issue 11, 2013, Pages 1329-1335

  Di Benedetto, Barbara ^a,b   Rupprecht, Rainer ^a,b   Czéh, Boldizsár ^c  

^a MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

^b UNIVERSITY OF REGENSBURG   (Germany)

^c UNIVERSITY OF PÉCS   (Hungary)

Author keywords

Astrocyte; Major depressive disorder; Microglia; Mood disorder; Synaptic plasticity

Indexed keywords

ANTIDEPRESSANT AGENT; CITALOPRAM; COMPLEMENT COMPONENT C1Q; EPHRIN RECEPTOR; FLUOXETINE; FLUVOXAMINE; INTERLEUKIN 1BETA; LIPOPOLYSACCHARIDE; PAROXETINE; SERTRALINE; TUMOR NECROSIS FACTOR ALPHA; VENLAFAXINE;

ARTICLE; ASTROCYTE; BRAIN DYSFUNCTION; CARDIOVASCULAR RISK; CELL COMMUNICATION; CHOLESTEROL BLOOD LEVEL; DRUG MECHANISM; GLIA CELL; HUMAN; INTRACELLULAR SIGNALING; MAJOR DEPRESSION; MICROGLIA; NERVE CELL NETWORK; NONHUMAN; PROTEIN EXPRESSION; SIDE EFFECT; SYNAPTIC TRANSMISSION; SYNAPTOGENESIS; TARGET CELL;

ANIMALS; ANTIDEPRESSIVE AGENTS; BRAIN; DEPRESSIVE DISORDER, MAJOR; DISEASE PROGRESSION; HUMANS; NEUROGLIA; NEURONAL PLASTICITY; NEURONS; SYNAPSES; SYNAPTIC TRANSMISSION;

EID: 84887917639     PISSN: 13894501     EISSN: 18735592     Source Type: Journal    
DOI: 10.2174/1389450111314110011     Document Type: Article

References (66)

1. Kettenmann H, Kirchhoff F and Verkhratsky A. Microglia: new roles for the synaptic stripper. Neuron 2013; 77: 10-18.
2. Molofsky AV, Krencik R, Ullian EM, et al. Astrocytes and disease: a neurodevelopmental perspective. Genes Dev 2012; 26: 891-907.
3. WHO (World Health Organization) 2012, http://www.who.int/mental_health/management/depression/definiti on/en/. [Accessed on: 09th November, 2012].
4. Bessa JM, Ferreira D, Melo I, et al. The mood-improving actions of antidepressants do not depend on neurogenesis but are associated with neuronal remodeling. Mol Psychiatry 2009; 14: 764-73.
5. Castren E. Is mood chemistry? Nat Rev Neurosci 2005; 6: 241-6.
6. Nemeroff CB and Owens MJ. Treatment of mood disorders. Nat Neurosci 2002; 5 Suppl: 1068-1070.
7. Miller RH and Raff MC. Fibrous and protoplasmic astrocytes are biochemically and developmentally distinct. J Neurosci 1984; 4: 585-92.
8. Araque A, Parpura V, Sanzgiri RP, et al. Tripartite synapses: glia, the unacknowledged partner. Trends Neurosci, 1999; 22: 208-15.
9. Paolicelli RC, Bolasco G, Pagani F, et al. Synaptic pruning by microglia is necessary for normal brain development. Science., 2011; 333: 1456-8.
10. Stevens B, Allen NJ, Vazquez LE, et al. The classical complement cascade mediates CNS synapse elimination. Cell 2007; 131: 1164-78.
11. Di Benedetto B and Rupprecht R. Targeting glia cells: novel perspectives for the treatment of neuropsychiatric diseases Curr Neuropharmacology 2012, CN-EPUB-20121120-1.
12. Czeh B and Di Benedetto B. Antidepressants act directly on astrocytes: Evidences and functional consequences. Eur Neuropsychopharmacol 2013; 23(3): 171-85.
13. Allen NJ, Bennett ML, Foo LC, et al. Astrocyte glypicans 4 and 6 promote formation of excitatory synapses via GluA1 AMPA receptors. Nature 2012; 486: 410-4.
14. Murai KK, Nguyen LN, Irie F, et al. Control of hippocampal dendritic spine morphology through ephrin-A3/EphA4 signaling. Nat Neurosci 2003; 6: 153-60.
15. Eroglu C, Allen NJ, Susman MW, et al. Gabapentin receptor alpha2delta-1 is a neuronal thrombospondin receptor responsible for excitatory CNS synaptogenesis. Cell 2009; 139: 380-92.
16. Ullian EM, Sapperstein SK, Christopherson KS, et al. Control of synapse number by glia. Science 2001; 291: 657-61.
17. Duman RS and Aghajanian GK. Synaptic dysfunction in depression: potential therapeutic targets. Science 2012; 338: 68-72.
18. Ullian EM, Christopherson KS and Barres BA. Role for glia in synaptogenesis. Glia 2004; 47: 209-16.
19. Kimelberg HK. Functions of mature mammalian astrocytes: a current view. Neuroscientist 2010; 16: 79-106.
20. Eroglu C. The role of astrocyte-secreted matricellular proteins in central nervous system development and function. J Cell Commun Signal 2009; 3: 167-76.
21. Pfrieger FW. Roles of glial cells in synapse development. Cell Mol Life Sci 2009; 66: 2037-47.
22. Mauch DH, Nagler K, Schumacher S, et al. CNS synaptogenesis promoted by glia-derived cholesterol. Science 2001; 294: 1354-7.
23. Christopherson KS, Ullian EM, Stokes CC, et al. Thrombospondins are astrocyte-secreted proteins that promote CNS synaptogenesis. Cell 2005; 120: 421-33.
24. Eroglu C and Barres BA. Regulation of synaptic connectivity by glia. Nature 2010; 468: 223-31.
25. Schafer DP, Lehrman EK, Kautzman AG, et al. Microglia sculpt postnatal neural circuits in an activity and complement-dependent manner. Neuron 2012; 74: 691-705.
26. Santello M and Volterra A. TNFalpha in synaptic function: switching gears. Trends Neurosci 2012; 35: 638-47.
27. Centonze D, Muzio L, Rossi S, et al. The link between inflammation, synaptic transmission and neurodegeneration in multiple sclerosis. Cell Death Differ 2010; 17: 1083-91.
28. Centonze D, Muzio L, Rossi S, et al. Inflammation triggers synaptic alteration and degeneration in experimental autoimmune encephalomyelitis. J Neurosci 2009; 29: 3442-52.
29. Turrigiano GG. The self-tuning neuron: synaptic scaling of excitatory synapses. Cell 2008; 135: 422-35.
30. Kaneko M, Stellwagen D, Malenka RC, et al. Tumor necrosis factor-alpha mediates one component of competitive, experience-dependent plasticity in developing visual cortex. Neuron 2008; 58: 673-80.
31. Pascual O, Ben Achour S, Rostaing P, et al. Microglia activation triggers astrocyte-mediated modulation of excitatory neurotransmission. Proc Natl Acad Sci USA 2012; 109: E197-205.
32. Bennett MR, Farnell L and Gibson WG. P2X7 regenerative-loop potentiation of glutamate synaptic transmission by microglia and astrocytes. J Theor Biol 2009; 261: 1-16.
33. Grunwald IC, Korte M, Adelmann G, et al. Hippocampal plasticity requires postsynaptic ephrinBs. Nat Neurosci 2004; 7: 33-40.
34. Murai KK and Pasquale EB. Eph receptors and ephrins in neuron-astrocyte communication at synapses. Glia 2011; 59: 1567-78.
35. Filosa A, Paixao S, Honsek SD, et al. Neuron-glia communication via EphA4/ephrin-A3 modulates LTP through glial glutamate transport. Nat Neurosci 2009; 12: 1285-92.
36. Licznerski P and Duman RS. Remodeling of axo-spinous synapses in the pathophysiology and treatment of depression. Neuroscience 2012; pii: S0306-4522(12)00977-3.
37. Alvarez VA and Sabatini BL. Anatomical and physiological plasticity of dendritic spines. Annu Rev Neurosci 2007; 30: 79-97.
38. Lai CS, Franke TF and Gan WB. Opposite effects of fear conditioning and extinction on dendritic spine remodelling. Nature 2012; 483: 87-91.
39. Stockmeier CA, Rajkowska G. Cellular abnormalities in depression: evidence from postmortem brain tissue. Dialogues Clin Neurosci 2004; 6: 185-97.
40. Rajkowska G and Miguel-Hidalgo JJ. Gliogenesis and glial pathology in depression. CNS Neurol Disord Drug Targets 2007; 6: 219-33.
41. Rajkowska G, Miguel-Hidalgo JJ, Wei J, et al. Morphometric evidence for neuronal and glial prefrontal cell pathology in major depression. Biol Psychiatry 1999; 45: 1085-98.
42. Banasr M and Duman RS. Glial loss in the prefrontal cortex is sufficient to induce depressive-like behaviors. Biol Psychiatry 2008; 64: 863-70.
43. Gosselin RD, Gibney S, O'Malley D, et al. Region specific decrease in glial fibrillary acidic protein immunoreactivity in the brain of a rat model of depression. Neuroscience 2009; 159: 915-25.
44. Lucae S, Salyakina D, Barden N, et al. P2RX7, a gene coding for a purinergic ligand-gated ion channel, is associated with major depressive disorder. Hum Mol Genet 2006; 15: 2438-45.
45. Sanacora G, Treccani G and Popoli M. Towards a glutamate hypothesis of depression: an emerging frontier of neuropsychopharmacology for mood disorders. Neuropharmacology 2012; 62: 63-77.
46. Chu Y, Jin X, Parada I, et al. Enhanced synaptic connectivity and epilepsy in C1q knockout mice. Proc Natl Acad Sci USA 2010; 107: 7975-80.
47. Boldrini M, Underwood MD, Hen R, et al. Antidepressants increase neural progenitor cells in the human hippocampus. Neuropsychopharmacology 2009; 34: 2376-89.
48. MacQueen G, Frodl T. The hippocampus in major depression: evidence for the convergence of the bench and bedside in psychiatric research? Mol Psychiatry 2011; 16: 252-64.
49. Hercher C, Canetti L, Turecki G, et al. Anterior cingulate pyramidal neurons display altered dendritic branching in depressed suicides. J Psychiatr Res 2010; 44: 286-93.
50. Soetanto A, Wilson RS, Talbot K, et al. Association of anxiety and depression with microtubule-associated protein 2 and synaptopodin-immunolabeled dendrite and spine densities in hippocampal CA3 of older humans. Arch Gen Psychiatry 2010; 67: 448-57.
51. Krishnan V and Nestler EJ. The molecular neurobiology of depression. Nature 2008; 455: 894-902.
52. Hinwood M, Tynan RJ, Charnley JL, et al. Chronic Stress Induced Remodeling of the Prefrontal Cortex: Structural Re-Organization of Microglia and the Inhibitory Effect of Minocycline. Cereb Cortex 2012, 10.1093/cercor/bhs151.
53. Tynan RJ, Naicker S, Hinwood M, et al. Chronic stress alters the density and morphology of microglia in a subset of stress-responsive brain regions. Brain Behav Immun 2010; 24: 1058-68.
54. Czeh B, Simon M, Schmelting B, et al. Astroglial plasticity in the hippocampus is affected by chronic psychosocial stress and concomitant fluoxetine treatment. Neuropsychopharmacology 2006; 31: 1616-26.
55. Roldan A, Gogg S, Ferrini M, et al. Glucocorticoid regulation of in vitro astrocyte phagocytosis. Biocell 1997; 21: 83-9.
56. McIntyre RS, Soczynska JK, Konarski JZ, et al. The effect of antidepressants on lipid homeostasis: a cardiac safety concern? Expert Opin Drug Saf 2006; 5: 523-37.
57. Partonen T, Haukka J, Virtamo J, et al. Association of low serum total cholesterol with major depression and suicide. Br J Psychiatry 1999; 175: 259-62.
58. Ditzen C, Tang N, Jastorff AM, et al. Cerebrospinal fluid biomarkers for major depression confirm relevance of associated pathophysiology. Neuropsychopharmacology 2012; 37: 1013-25.
59. Hummel J, Westphal S, Weber-Hamann B, et al. Serum lipoproteins improve after successful pharmacologic antidepressant treatment: a randomized open-label prospective trial. J Clin Psychiatry 2011; 72: 885-91.
60. Maya Vetencourt JF, Sale A, Viegi A, et al. The antidepressant fluoxetine restores plasticity in the adult visual cortex. Science 2008; 320: 385-8.
61. Karpova NN, Pickenhagen A, Lindholm J, et al. Fear erasure in mice requires synergy between antidepressant drugs and extinction training. Science 2011; 334: 1731-4.
62. Himmerich H, Binder EB, Kunzel HE, et al. Successful antidepressant therapy restores the disturbed interplay between TNF-alpha system and HPA axis. Biol Psychiatry 2006; 60: 882-8.
63. Tynan RJ, Weidenhofer J, Hinwood M, et al. A comparative examination of the anti-inflammatory effects of SSRI and SNRI antidepressants on LPS stimulated microglia. Brain Behav Immun 2011; 26: 469-79.
64. Thompson SM. Ephrins keep dendritic spines in shape. Nat Neurosci 2003; 6: 103-4.
65. Klintsova A, Levy WB and Desmond NL. Astrocytic volume fluctuates in the hippocampal CA1 region across the estrous cycle. Brain Res 1995; 690: 269-74.
66. Kessler RC, Berglund P, Demler O, et al. The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). JAMA 2003; 289: 3095-105.